Acculi Labs is a deep tech startup that provides life growth and home care solutions. The company  raised $1.5 million from Sabi Holding India in its new funding. The funding round saw the participation  of several new and existing investors. The startup plans to use these fresh proceeds to enhance its  platform, develop its conscious AI insight systems, and scale up operations, research, and  infrastructure development. 

The startup will mainly focus on enhancing its manpower and operational efficiency while  strengthening its market presence in India. The company secured Rs 5 crore from PirE Ventures during  its 2020 seed funding round. Acculi Labs offers a platform that provides home-based care available for  patients. The startup has flagship products including Lyfas which enables easy and early diagnostics while monitoring early-stage asymptomatic patients. This helps the patients to find doctors and treat  the disease at an early stage which reduces the future risks. The firm plans to introduce new services 

and increase its efficiency through this funding. This investment round highlights the trust of Sabi  Holding India in Acculi Lab’s market potential and business model. 

The Bengaluru company claimed to have expanded its services from a Cardiac health assessment  system provider to several health solutions using Lyfas. The startup provides its services via online  platforms and mobile applications. The platform claims to deliver detailed health reports of patients  within three minutes. The application is capable of non-invasively capturing psychophysiological  biomarkers. The company wants to change the home-based care for patients using its cutting-edge  technology. This fresh capital will be used to enhance the performance capability of the platform and  develop more innovative healthcare solutions. 

The startup has developed another flagship product, Lyra that removes the gap between carbon and  silicon life forms. The platform uses artificial intelligence and advanced technologies to provide a  seamless user experience. The company recently launched the Lyfas Udyam initiative to provide a  micro-entrepreneurial circular economy for startups and small entrepreneurs. The application is to  help small businesses run and start their businesses by offering them finance and processes. The  company will use a portion of this investment to strengthen its brand presence while expanding  globally. The Acculi labs face competition from other deep tech companies in this segment including  AliveCor, Imperative Care, and MYCLNQ Health. 

Conclusion: 

Acculi Labs is an AI-powered deep tech startup that raised 1.5 million USD in its new funding round  from Sabi Holding India Ltd. The company intends to use this amount to scale up its product infrastructure, enhance its platform, research, increase its workforce, product development, and  advance its technology. The startup previously secured Rs 5 crore in its seed funding round from PriE  Ventures. The Bengaluru startup aims to provide home-based care products and services to patients.  The platform provides detailed healthcare reports to patients in three minutes. The key offerings of  the startup include Lyfas which is a Cardiac health assessment system and Lyra which reduces the gap  between silicon and carbon life forms.